Based on conventional treatment, the randomized, placebo-controlled trial demonstrates the benefits of QSG on the levels of NT-proBNP, symptoms, heart function, 6 MWD, and quality of life for all heart failure patients. The gene discussed is NPPB; the disease is heart failure.